Company Performance: Revenue growth, profitability, and financial health directly impact investor confidence.

Sector Trends: The performance of the pharmaceutical industry and its growth prospects influence the valuation.

Regulatory Changes: Approvals, pricing regulations, and government policies in the pharmaceutical sector can cause fluctuations.

Market Sentiment: Overall investor confidence and risk appetite in the stock market impact trading volumes.

Competition: Competitive landscape and market share changes affect revenue projections.

Global Events: Global economic conditions and geopolitical events can influence investor decisions.

Raw Material Costs: Fluctuations in the price of raw materials impact production costs and profitability.

Currency Fluctuations: Exchange rate variations affect companies dealing in exports and imports.

Investor Perception: News and media coverage can shape sentiment.

Research and Development: Success in developing new products and patents adds value.

Management Decisions: Key strategic decisions can cause reevaluation.